SCHEMBL19009540

SCHEMBL19009540

Cc1ccc(-c2ccc(-c3nc(-c4ccccc4)nc(-c4ccccc4-c4ccccc4)n3)cc2)cn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.46
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
NFKB1 P19838 2/20 0.43
NFKB2 Q00653 2/20 0.43
RELA Q04206 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
LMNA P02545 2/20 0.42
USP1 O94782 1/20 0.40
WDR48 Q8TAF3 1/20 0.40
PKM P14618 1/20 0.40
TSHR P16473 2/20 0.40
ADORA3 P0DMS8 1/20 0.40
ALOX15 P16050 1/20 0.40
ADORA2A P29274 1/20 0.40
ADORA2B P29275 1/20 0.40
ADORA1 P30542 1/20 0.40
GPR55 Q9Y2T6 1/20 0.39
GBA1 P04062 1/20 0.39
PDK2 Q15119 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16189263 0.90 L3MBTL1 (0.55) L3MBTL1NPC1RAB9ANFKB1NFKB2
SCHEMBL17532861 0.90 L3MBTL1 (0.55) L3MBTL1NPC1RAB9ANFKB1NFKB2
SCHEMBL16189444 0.90 L3MBTL1 (0.55) L3MBTL1NPC1RAB9ANFKB1NFKB2
SCHEMBL24449153 0.85 L3MBTL1 (0.43) L3MBTL1NPC1RAB9ANFKB1NFKB2
SCHEMBL12628226 0.85 L3MBTL1 (0.57) L3MBTL1NPC1RAB9ANFKB1NFKB2
SCHEMBL16189349 0.84 LMNA (0.49) L3MBTL1NPC1RAB9ANFKB1NFKB2
SCHEMBL17720965 0.83 L3MBTL1 (0.52) L3MBTL1NPC1RAB9ANFKB1NFKB2
SCHEMBL2883216 0.83 L3MBTL1 (0.52) L3MBTL1NPC1RAB9ANFKB1NFKB2
SCHEMBL27455503 0.83 L3MBTL1 (0.52) L3MBTL1NPC1RAB9ANFKB1NFKB2
SCHEMBL21982359 0.83 LMNA (0.47) L3MBTL1NPC1RAB9ANFKB1NFKB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11329230-B2 Organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2022-05-10 US disclosed
US-20170317294-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-02 US disclosed
US-20170317294-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-02 US disclosed
US-20170179402-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-22 US disclosed
US-20170179402-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11329230-B2 Organic light-emitting device EML4, SUN2, TRPA1 L3MBTL1 324/4885NPC1 317/4885RAB9A 1433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.